YEATS2 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 6.703800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
1.303220E-01
Normal-vs-Stage2
7.640800E-01
Normal-vs-Stage3
1.165160E-01
Normal-vs-Stage4
8.979800E-01
Stage1-vs-Stage2
4.704600E-01
Stage1-vs-Stage3
2.394200E-01
Stage1-vs-Stage4
4.441800E-01
Stage2-vs-Stage3
1.207390E-01
Stage2-vs-Stage4
5.875400E-01
Stage3-vs-Stage4
2.064200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
6.753600E-01
Normal-vs-AfricanAmerican
5.459400E-01
Normal-vs-Asian
4.048200E-01
Caucasian-vs-AfricanAmerican
8.022600E-01
Caucasian-vs-Asian
4.359000E-01
AfricanAmerican-vs-Asian
7.708800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
6.234400E-01
Normal-vs-Female
7.417400E-01
Male-vs-Female
5.177200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
3.016200E-02
Normal-vs-Age(41-60Yrs)
8.243000E-01
Normal-vs-Age(61-80Yrs)
4.353200E-01
Normal-vs-Age(81-100Yrs)
7.069000E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
1.94330000002907E-06
Age(21-40Yrs)-vs-Age(61-80Yrs)
4.948100E-02
Age(21-40Yrs)-vs-Age(81-100Yrs)
5.133400E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
5.637000E-04
Age(41-60Yrs)-vs-Age(81-100Yrs)
3.180000E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
8.716600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
4.433800E-01
Normal-vs-Daily Drinker
2.512200E-01
Normal-vs-Weekly Drinker
4.926000E-01
Normal-vs-Occasional Drinker
7.832400E-01
Normal-vs-Social Drinker
7.349800E-01
Non Drinker-vs-Daily Drinker
8.473200E-01
Non Drinker-vs-Weekly Drinker
6.408600E-01
Non Drinker-vs-Occasional Drinker
4.466500E-02
Non Drinker-vs-Social Drinker
4.355700E-02
Daily Drinker-vs-Weekly Drinker
4.522000E-01
Daily Drinker-vs-Occasional Drinker
1.981800E-02
Daily Drinker-vs-Social Drinker
1.222360E-02
Weekly Drinker-vs-Occasional Drinker
1.484610E-01
Weekly Drinker-vs-Social Drinker
1.083370E-01
Occasional Drinker-vs-Social Drinker
9.896800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
4.444000E-01
Normal-vs-Grade 2
5.625200E-01
Normal-vs-Grade 3
1.111620E-01
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
2.620100E-04
Grade 1-vs-Grade 3
1.394260E-04
Grade 1-vs-Grade 4
4.444000E-01
Grade 2-vs-Grade 3
1.238600E-01
Grade 2-vs-Grade 4
5.625200E-01
Grade 3-vs-Grade 4
1.111620E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
4.126200E-01
Normal-vs-NonDiabetic
7.228000E-01
Diabetic-vs-NonDiabetic
1.860370E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
9.149200E-01
Normal-vs-NoPancreatitis
6.040200E-01
Pancreatitis-vs-NoPancreatitis
2.391800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
4.246400E-01
Normal-vs-N1
7.833400E-01
N0-vs-N1
1.181650E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
9.632200E-01
Normal-vs-TP53-NonMutant
3.109200E-01
TP53-Mutant-vs-TP53-NonMutant
9.197300E-04
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
